Ayala Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2002
Market Capitalization	6	4	2	20	21	13	Upgrade
Market Cap Growth	83.10%	83.10%	-89.14%	-5.57%	63.10%	-99.44%	Upgrade
Enterprise Value	10	7	-23	-21	2	-3	Upgrade
PE Ratio	-	-0.08	-0.15	-1.12	-0.80	-0.73	Upgrade
PS Ratio	491.92	307.38	8.73	6.20	84.09	5.59	Upgrade
PB Ratio	-0.16	-0.16	0.09	0.52	0.70	0.90	Upgrade
P/FCF Ratio	-0.19	-0.14	-0.14	-1.26	-0.94	-0.80	Upgrade
P/OCF Ratio	-0.19	-0.14	-0.14	-1.30	-0.97	-0.87	Upgrade
EV/Sales Ratio	756.08	571.53	-92.05	-6.63	8.36	-1.45	Upgrade
EV/EBITDA Ratio	-0.21	-0.21	1.46	1.14	-0.09	0.19	Upgrade
EV/EBIT Ratio	-0.21	-0.21	1.43	1.09	-0.08	0.19	Upgrade
EV/FCF Ratio	-0.36	-0.25	1.49	1.35	-0.09	0.21	Upgrade
Debt / Equity Ratio	-0.34	-0.34	0.06	0.00	0.20	0.02	Upgrade
Debt / EBITDA Ratio	-0.23	-0.23	0.00	0.00	-0.25	-0.02	Upgrade
Debt / FCF Ratio	-0.40	-0.28	0.00	0.00	-0.27	-0.02	Upgrade
Quick Ratio	0.20	0.20	11.05	5.37	7.79	3.24	Upgrade
Current Ratio	0.30	0.30	11.18	5.49	8.46	3.34	Upgrade
Asset Turnover	0.00	0.00	0.01	0.07	0.01	0.12	Upgrade
Interest Coverage	0	-2.30	0	-72.25	0	0	Upgrade
Return on Equity (ROE)	196.88%	196.88%	-60.77%	-45.93%	-87.70%	-123.10%	Upgrade
Return on Assets (ROA)	-289.96%	-289.96%	-55.38%	-38.18%	-68.70%	-88.72%	Upgrade
Return on Capital (ROIC)	225.24%	225.24%	-68.07%	-48.26%	-73.07%	-120.06%	Upgrade
Earnings Yield	-751.71%	-1203.02%	-657.96%	-88.91%	-124.41%	-136.40%	Upgrade
FCF Yield	-327.19%	-737.87%	-709.55%	-79.14%	-106.64%	-124.81%	Upgrade
Buyback Yield / Dilution	-230.97%	-230.97%	-12.70%	-111.61%	-301.14%	94.47%	Upgrade
Total Shareholder Return	-230.97%	-230.97%	-12.70%	-111.61%	-301.14%	94.47%	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.